SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-007810
Filing Date
2021-11-04
Accepted
2021-11-04 16:10:04
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 593087
2 CERTIFICATION nbio_ex311.htm EX-31.1 10275
3 CERTIFICATION nbio_ex312.htm EX-31.2 9691
4 CERTIFICATION nbio_ex321.htm EX-32.1 4803
5 CERTIFICATION nbio_ex322.htm EX-32.2 4553
  Complete submission text file 0001477932-21-007810.txt   3052157

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20210930.xsd EX-101.SCH 49539
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20210930_lab.xml EX-101.LAB 241481
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20210930_cal.xml EX-101.CAL 33641
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20210930_pre.xml EX-101.PRE 193789
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20210930_def.xml EX-101.DEF 91273
11 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 381912
Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 211380004
SIC: 2834 Pharmaceutical Preparations